Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Chemours (CC) Revenue (2016 - 2025)

Chemours has reported Revenue over the past 12 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Revenue at $1.3 billion for Q4 2025, down 2.21% from a year ago — trailing twelve months through Dec 2025 was $5.8 billion (changed 0.42% YoY), and the annual figure for FY2025 was $5.8 billion, changed 0.45%.
  • Revenue for Q4 2025 was $1.3 billion at Chemours, down from $1.5 billion in the prior quarter.
  • Over the last five years, Revenue for CC hit a ceiling of $1.9 billion in Q2 2022 and a floor of $1.3 billion in Q4 2025.
  • Median Revenue over the past 5 years was $1.5 billion (2023), compared with a mean of $1.5 billion.
  • Biggest five-year swings in Revenue: surged 51.42% in 2021 and later fell 15.53% in 2023.
  • Chemours' Revenue stood at $1.6 billion in 2021, then decreased by 15.05% to $1.3 billion in 2022, then grew by 2.24% to $1.4 billion in 2023, then decreased by 0.66% to $1.4 billion in 2024, then decreased by 2.21% to $1.3 billion in 2025.
  • The last three reported values for Revenue were $1.3 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.6 billion (Q2 2025) per Business Quant data.